相关实验视频

Updated: Jul 13, 2026

Surgical Procedures and Methodology for a Preclinical Murine Model of De Novo Mammary Cancer Metastasis

Surgical Procedures and Methodology for a Preclinical Murine Model of De Novo Mammary Cancer Metastasis

Published on: July 29, 2017

新辅助与辅助疗法对转移性乳腺癌:来自国家癌症数据库的见解 - 有一个胜利的策略吗?

Fatemeh Shojaeian¹, Mahtab Vasigh¹, Haydee Del Calvo¹

¹Department of Surgery,Division of Breast Surgical Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Annals of surgical oncology

|September 10, 2025

概括

辅助化疗改善了转移性乳腺癌 (MtBC) 患者的生存率. 前置手术后辅助疗法可能是最优的,而新辅助化疗和免疫疗法则显示出有前途.

科学领域:

在瘤学瘤学.
临床研究临床研究
癌症治疗方法癌症治疗方法

背景情况:

转移性乳腺癌 (MtBC) 是一种罕见的,具有攻击性的亚型,治疗反应不佳.
需要进行大型的国家队列分析,以比较MtBC的治疗策略和生存结果.

研究的目的:

为了比较转移性乳腺癌 (MtBC) 的治疗策略和生存结果.
评估化疗序列 (新辅助剂与辅助剂) 对MtBC患者的临床特征和存活率的影响.

主要方法:

对一大批被诊断患有MtBC的成年女性患者的国家队列的分析 (2006-2021).
根据化疗序列对患者进行分组:新辅助剂与辅助剂.
使用多变量分析评估临床特征,治疗方法和生存结果.

主要成果:

与新辅助疗法相比,辅助化疗与改善的整体存活率 (HR 0.65;P < 0.001) 有关 (80.7%与66.7%的5年生存率).
新辅助治疗的使用随着时间的推移而增加,并且在晚期晚期的年轻患者中更常见.
乳腺切除术,放射治疗,更高的收入和免疫疗法与更好的结果有关,而老年,结节参与,并发症和淋巴血管入侵与更高的死亡率相关.

结论:

辅助化疗和积极的局部治疗与MtBC中改善的生存率有关.
对可操作的MtBC进行量身定制的前期手术后续辅助治疗方法可能是最佳的.
越来越多的新辅助化疗使用和免疫疗法整合显示出有希望的生存趋势,需要进一步调查.

关键词:

辅助性化疗是一种辅助性化疗.免疫治疗是一种免疫疗法.甲基塑性乳腺癌是什么国家癌症数据库.新辅助化学疗法新辅助化学疗法生存结果的结果.治疗策略治疗策略

更多相关视频

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy

Published on: November 29, 2018

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...